Ascent Pharmahealth Ltd of Australia has a vast network of pharmaceutical business operations in Asia Pacific. Through our wholly owned subsidiaries of Ascent Pharmahealth Asia and Drug Houses of Australia (established in Singapore since 1930), the Ascent group brings the largest range of high quality Australian branded pharmaceutical products to the Asia Pacific region. Ascent's extensive range of pharmaceuticals include niche anti-cancer products and high end specialty drugs as well as over 100 prescription medicines that cover all the major therapeutic areas.

Ascent has global manufacturing partnerships with leading manufacturers in Europe, North America and Asia that not only meet the strict regulatory requirements of the Australian TGA but also those of the US FDA and European MHRA.

Ascent's growing footprint of sales and marketing operations has also allowed us to forge a number of strategic alliances with some of the world's leading multi-national drug makers to further broaden the range of high quality affordable medicines we can deliver to our medical and pharmacy customers.

Our goal is to bring the most comprehensive range of high quality branded prescription pharmaceuticals to the Asia Pacific region to meet the needs of demanding health professionals and their patients.